Amgen case.Amgen Case: A unit of Johnson & Johnson, that is a rival to and customer of Amgen Inc., is seeking to be added as a co-plaintiff in Amgen's patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit against drugmaker Roche Holding AG concerning anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin drugs that both U.S. companies market. Thousand Oaks-based Amgen sued Roche in November in an effort to prevent the Swiss drugmaker from introducing its anemia drug Cera into the U.S. market. Cera would compete with Amgen's Epogen and Aranesp. Johnson & Johnson's Ortho Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. Products L.P. sells a version of Epogen called Procrit under a 1985 licensing agreement with Amgen. Ortho and Amgen have a complex commercial relationship and a lengthy history of disputes over Procrit. Attorneys for New Brunswick New Brunswick, province, Canada New Brunswick, province (2001 pop. 729,498), 28,345 sq mi (73,433 sq km), including 519 sq mi (1,345 sq km) of water surface, E Canada. , N.J.- based Johnson & Johnson say the company is seeking to intervene in the suit because despite its status as an exclusive licensee, the company can't depend on Amgen to represent its interests. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion